Authors:
Kiran Pulidindi, Kavita Yadav
Download free PDF
Sodium Cocoyl Isethionate Market Size & Share 2026-2035
Report ID: GMI4139
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Sodium Cocoyl Isethionate Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

Sodium Cocoyl Isethionate (SCI) Market Size
The sodium cocoyl isethionate (SCI) market was valued at USD 265 million in 2025 and is estimated at USD 281 million in 2026, growing at a 4.90% CAGR (2026–2035) to reach USD 431 million by 2035. SCI is the coconut-derived anionic surfactant (CAS 61789-32-0) that gives syndet bars, shampoos, facial cleansers, and baby washes a creamy, low-irritation lather without sulfates. The market is measured at the manufacturer and supplier level in nominal USD.
Sodium Cocoyl Isethionate Market Key Takeaways
Market Leader: Clariant AG led with over 20% market share in 2025.
Leading Players: Top 5 players in this market include Clariant AG, Innospec Inc., Galaxy Surfactants Ltd., BASF SE, Croda International Plc, which collectively held a market share of 68% in 2025.
Demand is steady rather than spectacular. SCI is a specialty ingredient with a small number of qualified producers, and buyers rarely switch grades once a bar or cleanser formula is approved. Market trends therefore follow reformulation toward sulfate-free and solid formats, while raw-material cost and supplier reliability set the pace and pricing of that shift.
GMI Analyst View
Our discussions with industry experts indicate that global SCI volume reached 80,000 metric tons in 2025. That tonnage matters because it shows a supplier base selling a differentiated functional ingredient, not a bulk commodity, and it explains why qualification cycles, rather than spot price, decide most contract awards.
Sodium Cocoyl Isethionate (SCI) Market Trends, Growth Drivers & GMI Forecast Outlook
Mild-cleansing reformulation and new Asian supply lift demand, but coconut-oil cost and plant continuity can delay shipments and squeeze margins. Expect growth to favor bar and powder formats in Asia Pacific, while price pass-through and supplier outages shape timing in North America and Europe.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Clariant's Daya Bay project matters less for its size than for where it sits. Its multi-purpose plant gained a reactor for beauty surfactants, in a country where Chinese brands are launching sulfate-free baby, facial, and body products and where formulators have historically relied on European and US isethionate supply [1]Clariant. “Third Quarter / First Nine Months Figures 2025, Conference Call Transcript.” clariant.com. Shorter lead times and local technical support reduce inventory risk for converters, which tends to widen the number of customers who specify SCI. We expect the effect to show first in powder and flake grades through 2030.
Croda's 2025 result is a read-across to brand-owner behavior. Beauty Care volumes rose even as price and mix weakened, which tells us buyers are filling formulations with performance ingredients while pushing suppliers on price [2]Croda International Plc. “Results for the Year Ended 31 December 2025.” lse.co.uk. For SCI producers, premium skin-care and hair-care launches keep specifying mild cleansers, but contract pricing stays contested. Volume growth in these categories can carry the forecast through 2028 if brands keep launching rather than delisting, and the pace would soften if retail destocking returned.
The Innospec formats show how supply is moving closer to the bar line. Besides the Pureact I-78 and I-85 grades in flake, noodle, and powder form, the company sells ready-to-use flaked bases for combo bars, built around SCI with a fatty acid or SLMI [3]Innospec Inc. “Isethionates.” innospec.com. A small beauty brand without extrusion know-how can now launch a syndet or hybrid bar from a purchased base. That broadens the buyer pool for SCI beyond multinational personal-care groups and supports solid-format demand across the forecast period, particularly for noodles and needles. The risk is margin: base suppliers capture formulation value that pure SCI sellers do not.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Feedstock is the clearest cost pressure. SCI is built on coconut fatty acids, and lauric oil prices were lifted by drought-hit Philippine and Indonesian output and by higher biodiesel blending demand [4]International Coconut Community. “Market Review of Coconut Oil, September 2025.” coconutcommunity.org. Soap and syndet-bar makers, who buy flakes and noodles in tonnage and watch cost per bar closely, are the first to trade down or stretch the SCI share with cheaper surfactants. Producers with indexed contracts hold margin, while spot-exposed ones lose it. Relief depends on coconut harvests recovering and on palm-kernel oil substitution staying limited.
Innospec's shutdown illustrates single-site risk in a concentrated supply base. The company said repairs after the winter storm were its priority and that sequential growth was expected from the second quarter [5]Innospec Inc. “Innospec Reports First Quarter 2026 Financial Results.” innospec.com. For customers, a lost quarter means safety stock, second-source qualification, and in some cases a switch of grade, and each of those is slow to reverse. We treat 2026 North American volumes as partly deferred rather than lost, with the recovery shown in the second half if output normalizes.
BASF's disclosure points to a different pressure: suppliers are fighting for volume in personal care with price. The company cited lower demand in Care Chemicals and a lower contribution margin in almost all business areas, especially personal care [6]BASF SE. “Nutrition & Care, BASF Report 2025.” basf.com. When a large, integrated competitor competes for utilization, regional SCI makers find it harder to lift prices after raw-material increases. The consequence is slower capacity investment in Europe and the US. Margin repair in 2028 would reverse that, while a longer price war would favor lower-cost Asian producers.
GMI Analyst View
The forecast rests on a simple trade: formulators want sulfate-free, mild, and solid formats, and SCI delivers all three, but only if coconut-based supply stays dependable and affordable. Growth is likely to be steadier in Asia Pacific, where new local capacity meets expanding consumer launches, and more uneven in the West, where outages and margin pressure decide when volumes ship.
Sodium Cocoyl Isethionate (SCI) Market Segment Analysis
By Form
Within the sodium cocoyl isethionate (SCI) market, noodles and needles formed the largest form, at USD 111.3 million in 2025, which was 42.00% of the market. The format dominates because bar makers extrude it directly into syndet and combo bars without milling, and Innospec's I-78C and I-85C noodle grades sit squarely in that route. Soap-line converters value its flow and low dust, and that locks in repeat purchases from established bar plants.
Powder is expected to reach USD 125.9 million in 2035 and carries a 5.79% CAGR (2026–2035), the fastest growth among the forms. Powder suits facial cleansers, cleansing powders, shampoos, and liquid washes where it must disperse quickly, and brands launching waterless or low-water formats favor it. It also lets formulators match foam to sulfate-free blends, which is why supplier grades such as Pureact I-78P and I-85P exist.
Flakes hold 18.20% of the market in 2035 and grow at a 5.00% CAGR (2026–2035). They are the traditional soap-line form, compatible with milling equipment already installed at Asian and Latin American bar makers, and supplied at high active content. Flakes also feature in ready-made combo-bar bases, so their demand follows bar production rather than new cleanser launches.
Granules were USD 22.5 million in 2025 and are projected at USD 37.1 million in 2035. They are a niche, free-flowing option for dry-blend and low-dust handling, mainly for cleansing powders and some premium bar and sachet products. Buyers choose them for processing convenience and pay for it, which keeps volumes small but gives suppliers a margin that commodity forms lack.
By Application
Skin care was 40.00% of the market in 2025 and is projected at USD 167.3 million in 2035. Facial cleansers, syndet beauty bars, and sensitive-skin washes make it the most formulation-intensive outlet, with dermatologist-led claims and ingredient transparency driving specification. Buyers here pay for purity and consistent odor, so suppliers with tight quality control keep their position even when pricing is contested.
Hair care reached USD 58.3 million in 2025 and carries a 5.51% CAGR (2026–2035). Sulfate-free shampoos, cream shampoos, and solid shampoo bars all depend on SCI for rich, creamy foam and rinsability, and brand owners use it to anchor mild-cleansing claims. The category rewards grades that perform in blends with taurates, glycinates, and betaines, a pairing common in current formulation guides.
Body care holds 20.40% of the market in 2035, and its CAGR (2026–2035) is 4.84%. Body washes and combo bars carry high SCI volume per product, but buyers are price-aware and many hybrid bars dilute SCI with soap or cheaper surfactants. Growth therefore tracks bar volumes in Asia and Latin America, rather than premium launches in Europe.
Baby and kids care is expected to be USD 46.6 million in 2035, which would be 10.80% of the market. Pediatric and dermatologist guidance toward tear-free, sulfate-free cleansers makes baby washes and bars the application where mildness claims matter most. Brands accept higher ingredient cost for the safety story, and that gives SCI its strongest value-per-ton position outside premium skin care.
GMI Analyst View
Segment demand follows manufacturing route and claim strength more than consumer fashion. Noodles and flakes depend on the health of bar production, while powder and granules depend on cleanser and waterless launches. Applications where the claim is the purchase reason, namely baby, sensitive skin, and hair, favor suppliers who can document mildness and consistent sourcing, while body care stays the volume anchor and the most exposed to substitution.
Sodium Cocoyl Isethionate (SCI) Market Regional Analysis
North America Sodium Cocoyl Isethionate (SCI) Market Analysis
North America's sodium cocoyl isethionate (SCI) market was worth USD 71.5 million in 2025, and the region is projected to hold 25.70% of global revenue in 2035. It is a mature, syndet-bar-led market, with large multinational brand owners, long supplier qualification cycles, and a strong preference for documented, traceable supply. Local production at Clariant's Mount Holly plant and Innospec's North Carolina operations gives buyers regional sourcing, though it also concentrates outage risk.
United States
The United States generated USD 64.4 million in 2025, which was 90.07% of the regional market. It is where syndet beauty bars, sulfate-free shampoos, and dermatologist-recommended cleansers have the deepest retail distribution. Buyers demand supply security and ingredient transparency, and hard-water performance is a formulation concern in much of the Midwest.
Canada
Canada is expected to reach USD 11.1 million in 2035 and held 9.93% of the regional market in 2025. Demand comes from natural and eco-positioned bar and shampoo brands, many of them small, which buy through distributors in modest lots. That channel structure makes Canadian volumes sensitive to distributor stock levels and to US supplier availability.
Europe Sodium Cocoyl Isethionate (SCI) Market Analysis
Europe is projected to reach USD 104.8 million in 2035 and has a 4.33% CAGR (2026–2035). The region combines strict cosmetic-ingredient regulation, strong natural-cosmetics certification demand, and an established base of surfactant producers, which keeps mildness and bio-based claims central to buying decisions. Clariant's Tarragona plant in Spain gives European customers regional isethionate supply.
Germany
Germany was USD 14.9 million in 2025 and is projected at USD 23.1 million in 2035. As Europe's largest country market, it combines large personal-care manufacturers, drugstore private-label programs, and demanding natural-cosmetics standards. Buyers prefer certified and segregated bio-based grades, which benefits suppliers with documented sourcing.
France
France held 20.00% of the European market in 2025 and is expected to reach USD 21.0 million in 2035. Its dermocosmetic and pharmacy skin-care brands set the pace for sensitive-skin and baby cleansers, where mildness claims are essential. French formulators are quick adopters of new sulfate-free systems, which feeds demand for premium SCI grades.
United Kingdom
The United Kingdom is projected at 18.03% of the European market in 2035 and was USD 12.2 million in 2025. Independent solid-bar and eco-positioned brands, plus large grocery private labels, shape demand. Hard-water conditions across much of England push formulators to tune SCI with other surfactants, which makes technical support a selling point.
Spain
Spain was USD 5.4 million in 2025, which was 8.00% of Europe. Its role is as much about supply as demand, since Clariant's Tarragona plant sits there, and local converters benefit from short logistics. Retail private-label bars and shower products drive the home market.
Italy
Italy is expected to reach USD 8.4 million in 2035, equal to 8.02% of the European market. Italian contract manufacturers of cosmetics and personal-care products supply many international brands, so SCI demand is tied to export-led formulation work rather than domestic brands alone.
Asia Pacific Sodium Cocoyl Isethionate (SCI) Market Analysis
Asia Pacific was the largest region in 2025 with 35.00% of global revenue, and it is projected to reach USD 157.9 million in 2035. Large bar-soap and shampoo volumes, local sulfate-free launches, and new regional capacity explain its lead. Buyers range from multinationals with regional plants to fast-growing domestic brands that favor powder grades.
China
China was USD 44.5 million in 2025, equal to 48.00% of the regional market. It combines the largest consumer base with an active domestic brand scene in facial cleansers and baby care, and with new local production of mild surfactants. Local supply shortens lead times and lets brands iterate quickly.
India
India is expected to reach USD 23.7 million in 2035, which would be 15.01% of the regional market. Galaxy Surfactants gives it a domestic isethionate-capable producer and a base for exports. Demand comes from bar soap brands moving upmarket and a growing direct-to-consumer beauty segment.
Japan
Japan was USD 13.0 million in 2025 and is projected at USD 22.1 million in 2035. Its whip facial cleansers and premium body washes rely on creamy, fine-bubble lather, which suits SCI. Buyers demand tight purity and odor specifications, so supplier qualification is slow and sticky.
South Korea
South Korea held 7.99% of the regional market in 2025 and is expected to reach USD 12.6 million in 2035. K-beauty brands use mild, low-irritation cleansers as a base for skin-care routines, and export-led formulators constantly refresh product lines. That drives small-lot, frequent orders of high-purity grades.
Australia
Australia is projected at USD 7.9 million in 2035, up from USD 4.6 million in 2025. Its natural and eco-positioned brands favor palm-free, certified, and sulfate-free claims, and local manufacturers are small. Supply comes mostly through imports and distributors, which adds freight cost and lead time.
Latin America Sodium Cocoyl Isethionate (SCI) Market Analysis
Latin America was USD 19.9 million in 2025 and has a 5.47% CAGR (2026–2035). Bar soap remains a major cleansing format and local multinationals are expanding production. A surfactant plant being built in Mexico by Galaxy Surfactants for Unilever signals more regional sourcing of surfactants, which should help local converters over time.
Brazil
Brazil is expected to hold 50.15% of the regional market in 2035 and generated USD 9.9 million in 2025. It has the region's largest personal-care industry, with big domestic groups and direct-selling brands that buy at scale. Local currency swings and import costs shape purchasing patterns.
Mexico
Mexico was 25.13% of the regional market in 2025 and is projected at USD 8.5 million in 2035. Large consumer-goods plants and nearshoring investment support demand, and the new regional surfactant facility improves supply security for personal-care makers.
Argentina
Argentina was USD 2.0 million in 2025 and is projected at USD 3.4 million in 2035. Demand is concentrated in domestic personal-care brands, and import controls and currency volatility make buyers cautious. Orders tend to be small and distributor-led.
MEA Sodium Cocoyl Isethionate (SCI) Market Analysis
MEA is expected to hold 5.50% of global revenue in 2035 and carries a 6.03% CAGR (2026–2035). The base is small, so incremental brand launches and local manufacturing in the Gulf matter. Imported grades dominate, and distributors play a large role.
Saudi Arabia
Saudi Arabia was USD 3.3 million in 2025 and is projected at USD 5.9 million in 2035. Its personal-care manufacturing push under national industrial programs and a young consumer base for hair and skin products drive demand, mostly through imported ingredients.
UAE
The UAE held 25.00% of MEA in 2025 and is projected at 24.89% in 2035. Its role as a re-export and distribution hub means ingredient demand reflects regional trading volumes as much as local consumption, and premium and halal-positioned products are common.
South Africa
South Africa was USD 2.6 million in 2025 and is expected to hold 19.83% of the MEA market in 2035. It has the region's most developed domestic personal-care manufacturing base, and local brands use SCI in bars and shampoos, with imports covering most supply.
GMI Analyst View
Regional outcomes divide by how close supply sits to demand. Asia Pacific pairs the deepest bar and shampoo base with new local capacity, while North America and Europe depend on a few qualified plants and on certified, traceable grades. In Latin America and MEA, distributors and import logistics shape availability, so supply announcements matter more there than brand launches.
Sodium Cocoyl Isethionate (SCI) Market Share & Competitive Landscape
The sodium cocoyl isethionate (SCI) market is concentrated, and SCI market share sits with a small group of suppliers. The top five companies together held 68.00% of 2025 revenue, which reflects the small number of producers able to make isethionate esters at the purity and consistency that bar and cleanser makers demand. Competition turns on active content, odor and color, form range, regional supply, certification, and technical service rather than headline price. The field divides into global chemical groups with integrated surfactant platforms, specialty personal-care ingredient houses, and regional producers, mostly Asian.
Clariant AG
Clariant led with a 20.00% share in 2025. Its Hostapon SCI range is made at Tarragona, Spain, and Mount Holly, North Carolina, sites it expanded in 2021 to meet mild-surfactant demand. The company has since added a reactor for beauty surfactants at Daya Bay in China, which gives it supply close to the largest regional market.
Innospec Inc.
Innospec held 18.00% in 2025. Its Pureact range includes SCI in flake, noodle, and powder form, and it sells combo-bar bases that bundle SCI with fatty acids or SLMI. That gives it a direct route into bar makers who want a formulated base rather than a single ingredient.
Galaxy Surfactants Ltd.
Galaxy held 13.00% in 2025. The Indian producer has made mild surfactants and syndet formulations a focus of its specialty care business and is building a surfactant plant in Mexico for Unilever. Its strength is close ties to large Indian and multinational brand owners and low-cost Asian manufacturing.
BASF SE
BASF is one of the five leading suppliers. Its Care Chemicals division serves cosmetics, detergent, and cleaning customers across the world, and it runs a Solid 3.0 program promoting syndet shampoo bars to formulators. Scale in oleochemical surfactants lets it bundle isethionates with other mild cleansers.
Croda International Plc
Croda is also in the top five. Its Beauty Care business supplies formulation and effect ingredients for hair and skin products, and it is positioned around bio-based and specialty ingredients for premium brands. It competes on sustainability credentials and brand-owner relationships rather than volume.
Other significant participants include oleochemical and specialty-surfactant suppliers such as KLK OLEO, Nouryon, and Colonial Chemical, Inc., which supply mild surfactants and fatty-acid derivatives into personal-care formulations. The Lubrizol Corporation and Seppic S.A. compete through beauty ingredient portfolios and formulation support to brand owners.
JEEN International, Taiwan NJC Corporation, and Ningbo Inno Pharmchem Co., Ltd. serve regional markets and mid-sized brands as specialty ingredient and surfactant suppliers, mostly in North America and Asia.
Recent Industry Developments
Early 2026: Clariant's fourth-quarter 2025 results reported that Care Chemicals sales in Asia-Pacific rose at a high single-digit percentage rate as the new Daya Bay capacity lifted local volumes, while sales in Europe, the Middle East, and Africa declined at a mid-single-digit rate [7]Clariant. “Financial Results Media Release, Fourth Quarter / Full Year 2025.” clariant.com. The China plant began converting into revenue within months.
May 2026: Innospec's first-quarter 2026 results showed Performance Chemicals operating income down 46% after the January 2026 winter storm shut its North Carolina plants, with management prioritizing repairs and guiding to sequential improvement from the second quarter [5]Innospec Inc. “Innospec Reports First Quarter 2026 Financial Results.” innospec.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →